Active substance | tofersen |
Holder | Clinigen Healthcare Limited on behalf of Biogen |
Status | Running |
Indication | Amyotrophic Lateral Sclerosis (ALS) Associated with a Mutation in the Superoxide Dismutase 1 (SOD1) Gene |
Public documents | Approbation |
Information for the patient | |
Informed consent | |
Last update | 25/08/2023 |